{"entity":{"type":"insider","cik":"0001325232","url":"/insider/0001325232","json_url":"/insider/0001325232.json","name":"Willard Stephen H","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":3,"n_filings":2,"first":"2008-01-30","last":"2022-12-19","span_basis":"filed_date"},"name_variants":[{"name":"Willard Stephen H","source":"filing","n_filings":2,"first_seen":"2008-01-30","last_seen":"2022-12-19"}],"transactions":[{"id":6426132,"accession":"0001415889-22-012654","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-22-012654","line_url":"/filing/0001415889-22-012654#line-1","is_derivative":false,"issuer_cik":"0001325232","issuer_name":"NRX Pharmaceuticals, Inc.","issuer_ticker":"NRXP","issuer_name_source":null,"issuer_url":"/issuer/0001325232","owner_cik":"0001325232","owner_name":"Willard Stephen H","owner_display_name":"Willard Stephen H","owner_url":"/insider/0001325232","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":1.17,"price_display":"1.17","price_state":"stated","total_value":58500.0,"total_display":"58,500.00","total_whole":"58,500","shares_owned_after":50000.0,"shares_owned_after_display":"50,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-16","filed_date":"2022-12-19","scope":"insider"},{"id":3904255,"accession":"0001181431-08-006106","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-08-006106","line_url":"/filing/0001181431-08-006106","is_derivative":false,"issuer_cik":"0001015780","issuer_name":"E TRADE FINANCIAL CORP","issuer_ticker":"ETFC","issuer_name_source":null,"issuer_url":"/issuer/0001015780","owner_cik":"0001325232","owner_name":"Willard Stephen H","owner_display_name":"Willard Stephen H","owner_url":"/insider/0001325232","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":3.9852232,"price_display":"3.99","price_state":"stated","total_value":99630.58,"total_display":"99,630.58","total_whole":"99,631","shares_owned_after":43717.0,"shares_owned_after_display":"43,717","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-01-29","filed_date":"2008-01-30","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":3,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":3},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001719406","name":"NRX Pharmaceuticals, Inc.","url":"/issuer/0001719406","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","n_filings":1,"first_seen":"2022-12-19","last_seen":"2022-12-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001015780","name":"E TRADE FINANCIAL CORP","url":"/issuer/0001015780","role":"Director","n_filings":1,"first_seen":"2008-01-30","last_seen":"2008-01-30"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001325232","retrieved_at":"2026-08-23T03:27:28+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}